-- Independent brain-mapping study demonstrates measurable gains in cognitive efficiency, executive function, memory, and stress regulation after just seven days.
Active Duty RX™ today announced the release of results from an independent Quantitative Electroencephalogram (qEEG) Cognitive Impact Study, revealing significant improvements in cognitive performance and stress response among post-combat veterans following short-term use of Active Duty RX™ Clarity + Focus ES.
The observational study evaluated five veteran participants using qEEG brain mapping to measure neurological activity before initial product use (M1) and again after seven days of consistent use (M2). Quantitative EEG technology provides objective measurement of brainwave activity—including Delta, Theta, Alpha, and Beta frequencies—allowing researchers to assess changes in cognitive function, alertness, relaxation, and stress regulation.
The purpose of the study was to evaluate whether Clarity + Focus ES could support improvements in cognitive efficiency, executive function, memory performance, and stress handling over a short-term period. By analyzing changes in brainwave patterns, the study sought to determine whether the formulation offered measurable neurological benefits to participants.
Key Findings: Cognitive Improvement and Stress Reduction
Results from the study were consistently positive across all five participants. After just seven days of use, participants demonstrated significant improvements across multiple cognitive domains:
• Cognitive Efficiency increased by 60%, reflecting faster and more effective information processing. • Executive Function improved by 61%, including gains in attention, decision-making, and problem-solving.
• Memory performance—including short-term, working, and long-term memory—improved by 86%. • Stress levels decreased by 104%, indicating a substantial reduction in stress-related neurological activity.
qEEG brainwave analysis revealed favorable shifts associated with improved relaxation, heightened alertness, and enhanced stress resilience. These neurological changes suggest improved balance across key brain regions associated with cognition and emotional regulation.
James Johnson, Co-Founder of Active Duty RX, commented on the findings:
“What makes this study compelling is that we observed objective, measurable changes in brain activity in a very short time frame. The qEEG data reinforces our belief that Clarity + Focus ES can support neurological efficiency, cognitive performance, and stress regulation without relying on stimulant-based or habit-forming approaches. These early results are especially meaningful for the veteran community.”
In parallel with this independent qEEG evaluation, Dr. Tristan Lai, MD, Co-Founder of Active Duty RX, is currently conducting an additional clinic-based study within his medical practice. This ongoing study is designed to further evaluate neurological, cognitive, and stress-related outcomes associated with Active Duty RX formulations under clinical observation. Findings from this clinic-based evaluation are expected to be released upon completion.
Active Duty RX was founded by Ryan Early, widely known as “Farmer Ryan,” who serves as the company’s formulation, manufacturing, and distribution partner. Farmer Ryan brings extensive expertise in plant-based formulation, scalable manufacturing systems, and national distribution operations. His leadership ensures that Active Duty RX products are developed, produced, and delivered with consistency, safety, and performance in mind while remaining aligned with the company’s veteran-first mission and commitment to transparency.
Active Duty RX emphasizes that its products are designed to support cognitive and neurological wellness and are intended to complement—not replace—existing medical care or treatment plans. The company remains committed to continued research, transparency, and innovation in support of those who have served.
The complete qEEG study data, methodology overview, and supporting materials are available for public review at ActiveDutyRX.com.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. Active Duty RX products are not intended to diagnose, treat, cure, or prevent any disease. Individuals should consult a qualified healthcare professional regarding medical conditions or treatment decisions.
© 2025 Active Duty RX All Rights Reserved.
Anyone who has a specific question or comment about this article, or any article previously published on the site, is welcome to contact Active Duty RX via their website at https://www.activedutyrx.com/
Once again, the complete article is available to in full at https://americanwholesalehemp.com/farmer-ryan
Contact Info:
Name: Ryan Early
Email: Send Email
Organization: Farmer Ryan
Address: 8107 S I-35 Service Rd., Oklahoma City, Oklahoma 73149, United States
Website: https://farmerryan.com/
Release ID: 89180100